Fujita Toshio | Department Of Cardiology Nagaoka Red Cross Hospital
スポンサーリンク
概要
関連著者
-
ODA Hirotaka
Department of Cardiology, Niigata City General Hospital
-
TSUCHIDA Keiichi
Department of Cardiology, Niigata City General Hospital
-
Matsubara Taku
Division of Cardiology, Shinrakuen Hospital
-
Okabe Masaaki
Cardiovascular Center, Tachikawa General Hospital
-
Fujita Toshio
Department of Cardiology, Nagaoka Red Cross Hospital
-
Hatada Katsuharu
Division of Cardiology, Shinrakuen Hospital
-
Ikeda Yoshio
Cardiovascular Center, Tachikawa General Hospital
-
Matsubara Taku
Shinrakuen Hospital
-
Matsubara T
Division Of Cardiology Shinrakuen Hospital
-
Matsubara Taku
新潟市民病院 循環器科
-
Matsubara Taku
新潟大学 医歯学総合研究科循環器学分野
-
Oda Hirotaka
Department Of Cardiology Niigata City General Hospital
-
Tsuchida Keiichi
Department Of Cardiology Niigata City General Hospital
-
Okabe Masaaki
Cardiovascular Center Tachikawa General Hospital
-
Matsubara Taku
First Department of Internal Medicine
-
Matsubara T
First Department Of Internal Medicine Institute Of Nephrology Niigata University School Of Medicine
-
Matsubara Taku
Division Of Cardiology Shinrakuen Hospital
-
Hatada Katsuharu
Division Of Cardiology Shinrakuen Hospital
-
Hanzawa Kazuhiko
Thoracic And Cardiovascular Surgery Niigata University Graduate Shool Of Medicine
-
Hatada Katsuharu
Division Of Cardiology Niigata University Graduate School Of Medical And Dental Sciences
-
Ikeda Yoshio
Cardiovascular Center Tachikawa General Hospital
-
Fujita Toshio
Department Of Cardiology Nagaoka Red Cross Hospital
-
Fujita Toshio
Department Of Agricultural Chemistry Kyoto University
-
Okabe Masaaki
Cardiology, Tachikawa General Hospital, Japan
著作論文
- PE-295 Pioglitazone Remains Effective to Prevent Development of New Coronary Lesion in Diabetics at Medium Term : Results from Multicenter CHAMPION Trial(PE050,Diabetes 1 (H),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circ
- OE-340 Impact of Pioglitazone on Short-term Outcomes after Implantation of Sirolimus-Eluting Stents in Diabetics : Results from the CHAMPION Trial(Diabetes/Obesity/Metabolic syndrome(02)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of